Drug Discovery 2022: driving the next life science revolution

Speakers

Dr Mark Abbott
Peak Proteins Ltd
Prof Ian Adcock
Imperial College London
Mr Thomas Albanetti
AstraZeneca
United States
Mrs Catherine Alder
GSK
Dr Jelena Aleksic
PharmEnable
Gary Allenby
Charnwood Molecular
Dr Michael Anbar
Horizon Discovery, a PerkinElmer company
Dr Yahya Anvar
OKRA.ai
Prof Aravind Asokan
Duke University
United States
Dr Paul Avery
BioStrata
Dr Beatriz Baragana
Drug Discovery Unit, University of Dundee
Prof Phil Baran
Scripps Research Institute
United States
Dr Samantha Barichievy
AstraZeneca AB
Sweden
Ms Sharon Barnard
INTEGRA Bioscience Ltd
Dr John Bassett
MSD
United States
Dr Martin-Immanuel Bittner
Arctoris
Dr Sylvia F. Boj
HUB Organoids
Ms Vicky Bousgouni
Institute of Cancer Research
Dr Jo Brewer
Adaptimmune Limited
Dr Laura Calo
Ncardia
Netherlands
Prof Luigino Calzetta
University of Parma
Italy
Dr Katie Chapman
VC funded Biotech Company
Dr Kathryn Chapman
Milner Therapeutics Institute, University of Cambridge
Alice Cheesbrough
Cellenion
Dr Simon Chell
AstraZeneca
Dr Stuart Cockerill
Reviral/Pfizer
Dr Margaret Anne Craig
Axol Bioscience
James Curtis
Standard Bio Tools
Dr Richard Cuthbert
Bio-Rad
Dr Lenny Dang
Agios Pharmaceuticals Inc
United States
Kam Dhaliwal
bit.bio
Kam Dhaliwal
bit.bio
Claire Dobson
AstraZeneca
Dr Barbara Domayne-Hayman
Francis Crick Institute
Ms Phoebe Feng
Targetmol chemicals Inc.
United States
David Fischer
CRL
Mr Tom Fleming
Arctoris
Mr Daniel Fordham
Oxford Nanopore Technologies
Mr Tom Froggatt
Singular Talent
Prof A Ganesan
University Of East Anglia
Dr Mathew Garnett
Wellcome Sanger Institute
Mrs Becky Garton
Royal Society of Chemistry
Dr Martine Geraerts
UCB Biopharma
Belgium
Mrs Katrin Geschwendt
Araceli Biosciences
Germany
Miss Jessica Graham
Newcastle University
Mark Graham
Beckman Coulter UK Ltd.
Dr Ed Griffen
MedChemica Ltd
Stephen Hague
10x Genomics
Dr Benjamin Haibe-Kains
Princess Margaret Cancer Centre
Canada
Ms Kristin Halfpenny
Araceli Biosciences
United States
Dr Anne Hammerstein
SPT Labtech
Imran Haneef
Lablogic
Dr Richard Harbottle
German Cancer Research Centre (DKFZ)
Germany
Ms Elizabeth Hardaker
Astrazeneca
Dr Robert Heald
Artios Pharma
Chris Herring
Adaptimmune
Dr Peter Horvath
Biological Research Centre, Szeged
Hungary
Dr Rachel Howard-Jones
Imagen Therapeutics on behalf of Nexcelom
Dr Michael Howell
The Francis Crick Institute
Dr Rebecca Hughes
University of Edinburgh
Dr Zoe Hughes-Thomas
GSK
Dr Jon Hutchinson
GlaxoSmithKline
Dr John Irwin
University of California San Francisco
United States
Ms Hanadi Jabado
Sana Capital
Dr Heulyn Jones
Cardiff University
Dr Allan Jordan
Sygnature Discovery
Dr Joshua Kangas
Carnegie Mellon University
United States
Dr Samantha Kanza
University of Southampton
Paul Kendall
Festo
Dr Catherine Kettleborough
LifeArc, The Accelerator
Mr Sanj Kumar
ELRIG
Mr Nathaniel Lam
GSK
Dr Romain Lara
AstraZeneca
Dr Celine Legros
Eurofins Discovery
France
Mrs Melanie Leveridge
GSK
Ms Sian Lewis
MSD
Katie Lim
Royal Society of Chemistry
Miss Poppy Llowarch
AstraZeneca
Mr Chris Luche
Sanger Institute
David Madge
WuXi AppTec
Melanie Maerken
Synthego
Dr Martin Main
Medicines Discovery Catapult
Dr Craig Malcolm
Promega UK Ltd
Isabel Martin Caballero
Pelago Bioscience
Mrs ROSLYN McConnell
Avantor
Mr Adam McGinnis
Azenta UK Ltd
Dr Paul Mears
Science Solutions Recruitment
Prof Aline Miller
Manchester BIOGEL / University of Manchester
Dr Louise Modis
Mogrify
Dr Lisa Mohamet
GlaxoSmtihKline
Dr Rachel Moore
AstraZeneca
Dr Federica Morandi
F Hoffmann-La Roche
Switzerland
Dr Anna Morgan
Physiology & Pharmacology, Kingston University
Dr Shaun Pennington
LSTM
Oliver Pentinmaki
Benchling
Mr James Pilling
AstraZeneca
Dr Simon Pitchford
King's College London
Dr Andrew Powell
GlaxoSmithKline
David Powell
LifeArc
Rabinder Prinjha
GlaxoSmithKline
Mr Adam Prosho
CBRE-GWS
Dr Karthi Rajamani
Takara Bio Europe
France
Dr Andrew Ratcliffe
Domainex Ltd
Dr Nicola Richmond
BenevolentAI
Mario Richter
AbbVie Deutschland GmbH & Co. KG
Germany
Dr Katrin Rittinger
Francis Crick Institute
Dr Douglas Ross-Thriepland
AstraZeneca
Dr Michael Salako
Start Codon
Dr Janine Scholefield
CSIR, South Africa
South Africa
Dr Jamie Scott
AstraZeneca
Mr Maximilian Seifermann
Karlsruhe Institute of Technology
Germany
Dr Steven Shave
University of Edinburgh & GSK
Prof Dave Singh
University of Manchester
Sarah Skerrat
CHARM Therapeutics
Dr John Skidmore
University of Cambridge
Prof Berend Snijder
ETH Zurich
Switzerland
Dr Mark Soave
OMass Therapeutics
Dr Harriet Stanway-Gordon
Newcastle University
Prof Molly Stevens
Imperial College London
Martin Swarbrick
Ryvu Therapeutics
Prof Ali Tavassoli
Curve Therapeutics & University of Southampton
Dr Del Trezise
Sartorius AG
Kirsten Tschapalda
Roche
Dr Nicola Wallis
Astex
Mrs Joanne Walter
Fida Biosystems ApS
Denmark
Prof Simon Ward
University of Cardiff
Mrs Sue Ward
Illumina
Catherine Wark
BMG Labtech
Prof Wisia Wedzicha
Imperial College London
Mr Charles Whalley
British Pharmacological Society
Dr Mary Wheldon
Drug Discovery Unit, University of Dundee
Sponsor